Your mission
This position will be part of Adragos Athens Sales team, member of Adragos Pharma, a globally operating pharmaceutical contract Development and Manufacturing Organisation (CDMO). Adragos Athens is focused on expanding its output and customer base through new business development and offers a full range of development activities for Generics and Generics Plus. We are seeking a dynamic professional with Business Development experience, a technical background and an understanding of R&D service in the Pharmaceutical industry.
Key Responsibilities:
- Participate to the BD efforts to maximize company revenue and generate new business opportunities
- Identify, evaluate, propose and bring on board new business leads and opportunities (Prospecting)
- Present company and its offering to prospects, identifying common ground and suitable business model for cooperation
- Overall management of contracts (existing customers, new deals)
- Work closely with legal, financial and R&D teams to structure and finalize agreements
- Closely interface with the other departments in order to effectively follow up on the appropriate contractual obligations to the client
- Responsible in the business cases’ evaluation and proposal to the Head of BD + MD as appropriate, with the Strategy BDM
- Oversee and manage the implementation of partnership agreements, ensuring all contractual obligations are met
- Monitor and report on the progress of partnerships and collaborations
- Ensure timely invoicing in cooperation with Finance
- Support the effective preparation and participation of Adragos Athens in expos, conferences and other venues.
- Prepare detailed reports and presentations for senior management on business development activities and outcomes.
About us
Adragos Pharma was founded in 2020 to build a leading global CDMO player in the Small Molecule space. We are pursuing an ambitious Buy&Build growth strategy: within the next three-five years, we will acquire and integrate pharmaceutical production sites in Europe and North America to become a market leader in the CDMO segment.
CDMOs (Contract Development and Manufacturing Organization), produce approx. 25% of drugs that are available in pharmacies and clinics, thus playing a vital role in medication access for millions of patients globally. Due to the increasing pressure on healthcare systems (aging population, prevalence of chronic disease, etc.), the importance of CDMOs is only going to grow.
Since 2020, we grew the team from three to more than 700 people, partnered with Scandinavian PE, FSN Capital, and a leading German Family Office, Prange Group. Until today, we acquired five production and development sites in Germany, France, Greece, Norway and Japan. You want to be part of our dynamic growth? Then apply now!
